Skip to main content
. 2010 Sep 7;54(11):4611–4618. doi: 10.1128/AAC.00787-10

TABLE 2.

Activity of BI 201335, telaprevir, and boceprevir against representative serine and cysteine proteases

Inhibitor IC50 (nM) against the following proteasea:
HLE CatB
BI 201335 >30,000 26,000 ± 1,900
Telaprevir 680 ± 10 2,300 ± 900
Boceprevir 17,000 ± 1,000 6,200 ± 1,000
a

Fifty percent concentrations (IC50s) shown are means ± standard deviations from three separate experiments. HLE, human leukocyte elastase; CatB, cathepsin B.